The Board granted a 100 percent rating for Chronic Myelogenous Leukemia from June 4, 2014 to September 27, 2018 and a 30 percent rating thereafter. The Veteran's CML was in remission during the latter period.
The deciding factor: The Veteran's CML entered complete molecular remission as of September 27, 2018, warranting a 100 percent rating from June 4, 2014 to that date. After this point, he continued on tyrosine kinase inhibitor therapy and experienced symptoms such as weakness and fatigue, which are most consistent with a 30 percent rating under Diagnostic Code 7700.
- Claimed conditions
- Chronic Myelogenous Leukemia (CML)
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 30%
- Decision date
- April 30, 2026
- Citation
- A26040864
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A26040864.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Veteran's service connection for Chronic Myelogenous Leukemia (CML) is granted. The issue of service connection for Behcet's Syndrome, due to presumed exposure at Camp Lejeune, is remanded.
- Granted
The Veteran is granted an effective date of August 7, 2023 for service connection of Chronic Myelogenous Leukemia (CML), which was denied in a previous rating decision. The claim was received within one year of the PACT Act's effective date and meets eligibility criteria.
- Denied
The Veteran's cause of death, respiratory failure and overwhelming sepsis with contributory hypotension, was attributed to his underlying Chronic Myelogenous Leukemia (CML), which developed as a result of the bone marrow transplant he underwent due to CML. The Board found that service connection for CML could not be established because there was no evidence showing it was incurred during or aggravated by service.
- Granted
The Veteran's claim for an earlier effective date of July 9, 2010 for service connection of CML was granted. The VA treatment record dated October 26, 2010, which reflected the Veteran had a diagnosis of CML and was being treated for it, was considered new and material evidence within one year of the October 15, 2010 rating decision.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.